Paragon Fine And Speciality Chemicals IPO is now live, offering a book built issue worth Rs 51.66 crores, comprising an entirely fresh issue of 51.66 lakh shares.
Subscription for the Paragon Fine And Speciality Chemicals IPO opens on October 26, 2023, and concludes on October 30, 2023. The Basis of Allotment is set to be finalized by Thursday, November 2, 2023. Get ready for trading as Paragon Fine And Speciality Chemicals IPO is scheduled to list on NSE SME, with a tentative listing date fixed for Tuesday, November 7, 2023.
Investors can participate within a price band of ₹95 to ₹100 per share. The minimum application lot size stands at 1200 shares, requiring a minimum investment of ₹120,000 for retail investors. High Net Worth Individuals (HNI) can invest with a minimum of 2 lots (2,400 shares), amounting to ₹240,000.
Paragon Fine And Speciality Chemicals IPO is managed by the expert team at Hem Securities Limited, serving as the book running lead manager, and Bigshare Services Pvt Ltd, acting as the registrar for the issue. Hem Finlease has been appointed as the market maker for this exciting IPO opportunity.
For comprehensive insights, please refer to Paragon Fine And Speciality Chemicals IPO RHP for detailed information on this promising investment prospect.
Paragon Fine And Speciality Chemicals IPO Details
|IPO Date||October 26, 2023 to October 30, 2023|
|Face Value||₹10 per share|
|Price Band||₹95 to ₹100 per share|
|Lot Size||1200 Shares|
|Total Issue Size||5,166,000 shares (aggregating up to ₹51.66 Cr)|
|Fresh Issue||5,166,000 shares (aggregating up to ₹51.66 Cr)|
|Issue Type||Book Built Issue IPO|
|Listing At||NSE SME|
|Share holding pre issue||14,400,000|
|Share holding post issue||19,566,000|
Paragon Fine And Speciality Chemicals IPO Dates
The Paragon Fine And Speciality Chemicals IPO opens on October 26, 2023, and closes on October 30, 2023. The finalization of the Basis of Allotment for Paragon Fine And Speciality Chemicals IPO will be done on Thursday, November 2, 2023, and the allotted shares will be credited to your demat account by Monday, November 6, 2023.
|IPO Open Date||Thursday, October 26, 2023|
|IPO Close Date||Monday, October 30, 2023|
|Basis of Allotment||Thursday, November 2, 2023|
|Initiation of Refunds||Friday, November 3, 2023|
|Credit of Shares to Demat||Monday, November 6, 2023|
|Listing Date||Tuesday, November 7, 2023|
Paragon Fine And Speciality Chemicals IPO Lot Size
Explore Investment Options: Interested investors have the flexibility to bid for a minimum of 1200 shares and increase their investment in multiples of this figure. The table below provides details on the minimum and maximum investment opportunities available for both retail investors and High Net Worth Individuals (HNI), including the corresponding number of shares and investment amounts.
Objects of the Paragon Fine And Speciality Chemicals IPO
The company intends to utilize the proceeds of the Issue to meet the following objectives: –
- Funding capital expenditure towards civil construction work in the existing premises of the factory
- Funding capital expenditure towards civil construction work in Plot No 10/A, Situated at Survey No. 1359, 1360 Village-Viramgam Taluka- Viramgam, District-Ahmedabad-382150, Gujarat.
- Repayment in full or in part, of certain of our outstanding borrowings;
- Funding Capital Expenditure towards the installation of additional plant and machinery for Expansion.
- Funding to meet working capital requirements 6. General Corporate Purpose.
About Paragon Fine And Speciality Chemicals Limited IPO
Founded in 2004, our company specializes in custom synthesis and the manufacturing of specialized chemical intermediates involving intricate and differentiated chemistry. We take pride in producing a diverse range of Pharma Intermediates, AGRO Intermediates, Cosmetics Intermediates, Pigment Intermediates, and Dye Intermediates for a broad Indian and global customer base.
Located in Viramgam District, Ahmedabad, Gujarat, our manufacturing unit spans approximately 7000 square meters and is equipped with advanced reactors for pioneering research and the development of new products.
Our dedicated Research and Development (R&D) team has achieved significant milestones, conducting multi-step synthesis and creating numerous innovative molecules in the field of specialty intermediates. This success has bolstered our product portfolio, which reached around 140 products by Fiscal 2023. As of March 31, 2023, our skilled team comprises 14 technocrats passionately engaged in R&D activities.
We take pride in our competitive strengths, which include:
- Wide Range of Customizable Products: We offer a versatile array of products tailored to meet unique requirements, ensuring customer satisfaction.
- Focus on R&D Excellence: Our emphasis on research and development enables us to leverage complex chemistry and cutting-edge technology, ensuring continuous innovation.
- Established Customer Relationships: We have fostered enduring relationships with customers from various nationalities, building trust and loyalty over the years.
- State-of-the-Art Manufacturing Unit: Our in-house manufacturing unit is equipped with advanced technologies and processes, ensuring efficiency and precision in our production.
What sets us apart further is the wealth of experience and domain expertise possessed by our Promoters and Senior Management, guaranteeing our commitment to excellence and industry leadership.